SG Americas Securities, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25
-7.4%
18,591
+25.0%
0.00%
Q2 2023$27
-80.7%
14,868
-58.5%
0.00%
-100.0%
Q1 2023$140
-99.8%
35,864
+135.7%
0.00%
+100.0%
Q3 2022$83,000
-79.8%
15,214
-83.3%
0.00%
-75.0%
Q2 2022$411,000
+170.4%
91,233
+284.7%
0.00%
+300.0%
Q4 2021$152,000
-38.2%
23,716
-43.8%
0.00%0.0%
Q3 2021$246,000
+43.9%
42,199
+159.4%
0.00%0.0%
Q1 2021$171,000
-81.7%
16,269
-74.5%
0.00%
-83.3%
Q3 2020$932,000
+135.9%
63,865
+206.3%
0.01%
+100.0%
Q2 2020$395,000
+70.3%
20,850
+72.7%
0.00%
+50.0%
Q1 2020$232,000
+38.9%
12,074
+38.5%
0.00%0.0%
Q4 2019$167,000
+72.2%
8,719
-13.6%
0.00%
+100.0%
Q4 2017$97,000
-32.6%
10,094
-23.0%
0.00%0.0%
Q3 2017$144,000
+54.8%
13,116
+28.0%
0.00%0.0%
Q2 2017$93,000
-35.4%
10,249
-33.2%
0.00%0.0%
Q4 2016$144,000
-11.7%
15,343
-0.9%
0.00%0.0%
Q3 2015$163,000
-18.1%
15,482
+190.6%
0.00%0.0%
Q4 2014$199,000
+76.1%
5,327
+64.4%
0.00%0.0%
Q3 2014$113,000
-38.6%
3,241
-18.2%
0.00%0.0%
Q2 2014$184,0003,9610.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders